Blog

Archive for the ‘business’ category: Page 173

Jul 17, 2020

AI 50 Founders Predict What Artificial Intelligence Will Look Like After Covid-19

Posted by in categories: biotech/medical, business, robotics/AI, security

Do you agree with these predictions?


The first few months of 2020 have radically reshaped the way we work and how the world gets things done. While the wide use of robotaxis or self-driving freight trucks isn’t yet in place, the Covid-19 pandemic has hurried the introduction of artificial intelligence across all industries. Whether through outbreak tracing or contactless customer pay interactions, the impact has been immediate, but it also provides a window into what’s to come. The second annual ForbesAI 50, which highlights the most promising U.S.-based artificial intelligence companies, features a group of founders who are already pondering what their space will look like in the future, though all agree that Covid-19 has permanently accelerated or altered the spread of AI.

“We have seen two years of digital transformation in the course of the last two months,” Abnormal Security CEO Evan Reiser told Forbes in May. As more parts of a company are forced to move online, Reiser expects to see AI being put to use to help businesses analyze the newly available data or to increase efficiency.

Continue reading “AI 50 Founders Predict What Artificial Intelligence Will Look Like After Covid-19” »

Jul 16, 2020

Coronavirus Vaccines in Phase 3 Development | The State of Science

Posted by in categories: biotech/medical, business, science

Tired of the coronavirus? Well, the good news is that there are several vaccines in development that are in their final phase of clinical testing before they can be approved for public usage. The bad thing, however, is the fact that there are only so many doses each vaccine manufacturer can make- meaning solving the pandemic will be as much a problem of distribution and manufacturing as it is research and development.

PS: The stock footage from this photo comes from Videvo!

Continue reading “Coronavirus Vaccines in Phase 3 Development | The State of Science” »

Jul 16, 2020

Samsung reveals its 6G vision, expects to provide 1,000 Gbps peak data rate

Posted by in categories: business, internet

A ZDNet report, citing Samsung’s white paper, stated that the sector of the International Telecommunication Union (ITU) responsible for radio communication, ITU-R, is likely to commence their work to define a 6G vision in 2021.

The 3G took 15 years to be defined, while the time taken for the 5G was eight years.

Samsung last year also asserted that it would continue to invest and pre-study future business, including the sixth generation mobile network, reported GizChina.

Jul 16, 2020

The Great Reset 2020: What Would the Near Future Post-Pandemic World Look Like?

Posted by in categories: biotech/medical, business, health, transhumanism

The global health crisis is accelerating meta-trends and hurling civilization towards the transhuman future. The disruptors are being disrupted, and the rush is on to digitize and virtualize everything in weeks’ time that otherwise would have taken a few years to play out. Recent surveys show that we have compressed five years in business and consumer digital adoption within a couple of months. https://www.ecstadelic.net/top-stories/the-great-reset-2020-…-look-like

#GreatReset2020

Continue reading “The Great Reset 2020: What Would the Near Future Post-Pandemic World Look Like?” »

Jul 15, 2020

Deep Dive Into Big Pharma AI Productivity: One Study Shaking The Pharmaceutical Industry

Posted by in categories: biotech/medical, business, chemistry, health, information science, robotics/AI

No industry will be spared.


The pharmaceutical business is perhaps the only industry on the planet, where to get the product from idea to market the company needs to spend about a decade, several billion dollars, and there is about 90% chance of failure. It is very different from the IT business, where only the paranoid survive but a business where executives need to plan decades ahead and execute. So when the revolution in artificial intelligence fueled by credible advances in deep learning hit in 2013–2014, the pharmaceutical industry executives got interested but did not immediately jump on the bandwagon. Many pharmaceutical companies started investing heavily in internal data science R&D but without a coordinated strategy it looked more like re-branding exercise with the many heads of data science, digital, and AI in one organization and often in one department. And while some of the pharmaceutical companies invested in AI startups no sizable acquisitions were made to date. Most discussions with AI startups started with “show me a clinical asset in Phase III where you identified a target and generated a molecule using AI?” or “how are you different from a myriad of other AI startups?” often coming from the newly-minted heads of data science strategy who, in theory, need to know the market.

However, some of the pharmaceutical companies managed to demonstrate very impressive results in the individual segments of drug discovery and development. For example, around 2018 AstraZeneca started publishing in generative chemistry and by 2019 published several impressive papers that were noticed by the community. Several other pharmaceutical companies demonstrated impressive internal modules and Eli Lilly built an impressive AI-powered robotics lab in cooperation with a startup.

Continue reading “Deep Dive Into Big Pharma AI Productivity: One Study Shaking The Pharmaceutical Industry” »

Jul 13, 2020

Regeneron Stock Hits Another Record High On Coronavirus Treatment Potential

Posted by in categories: biotech/medical, business, finance

Regeneron rose as much as 2.4% in the stock market today, touching a record high of 655.93. Shares seesawed in a small range Thursday before ending the day up a small fraction, at 640.63. The peak price topped Regeneron stock’s previous high of 653.53, touched on Tuesday. Regeneron is part of the IBD Biomed/Biotech group, which ranks No. 14 out of 197 industry groups tracked. The group is just off its all-time high, which it hit on June 23.


Regeneron Pharmaceuticals (REGN) jumped to an all-time high Thursday, its second of the week, as analysts remain bullish on Regeneron stock due to its coronavirus treatment and other businesses.

Jul 13, 2020

Panasonic launches mobility service at Tokyo transportation hub

Posted by in categories: business, robotics/AI, transportation

Panasonic has begun testing robotic mobility devices at the newly constructed Takanawa Gateway train station in Tokyo.

The effort is art of a plan to bring a series of automated services to the airport and surrounding facilities that are part of a massive redevelopment project in the surrounding Shinagawa business district.

Three mobility devices, essentially intelligent electric wheelchairs, will be used as a single group in the trial. The experiment will focus on ensuring the safety of passengers with mobility issues as they are transported throughout the huge facilities.

Jul 13, 2020

Google signs up Verizon for its AI-powered contact center services

Posted by in categories: business, mobile phones, robotics/AI

Google today announced that it has signed up Verizon as the newest customer of its Google Cloud Contact Center AI service, which aims to bring natural language recognition to the often inscrutable phone menus that many companies still use today (disclaimer: TechCrunch is part of the Verizon Media Group). For Google, that’s a major win, but it’s also a chance for the Google Cloud team to highlight some of the work it has done in this area. It’s also worth noting that the Contact Center AI product is a good example of Google Cloud’s strategy of packaging up many of its disparate technologies into products that solve specific problems.

“A big part of our approach is that machine learning has enormous power but it’s hard for people,” Google Cloud CEO Thomas Kurian told me in an interview ahead of today’s announcement. “Instead of telling people, ‘well, here’s our natural language processing tools, here is speech recognition, here is text-to-speech and speech-to-text — and why don’t you just write a big neural network of your own to process all that?’ Very few companies can do that well. We thought that we can take the collection of these things and bring that as a solution to people to solve a business problem. And it’s much easier for them when we do that and […] that it’s a big part of our strategy to take our expertise in machine intelligence and artificial intelligence and build domain-specific solutions for a number of customers.”

The company first announced Contact Center AI at its Cloud Next conference two years ago and it became generally available last November. The promise here is that it will allow businesses to build smarter contact center solutions that rely on speech recognition to provide customers with personalized support while it also allows human agents to focus on more complex issues. A lot of this is driven by Google Cloud’s Dialogflow tool for building conversational experiences across multiple channels.

Jul 11, 2020

Surviving Mars | Humanity’s First Mars Base

Posted by in categories: business, space travel

The coming two decades are scheduled to be very interesting decades for human space exploration and colonization. One of the things on America’s agenda for space exploration is creating humanity’s first Mars base, which will most likely happen in the 2030s and 2040s. If you are interested in what this Moon base will look like, please take a look at this video!

Discord Link: https://discord.gg/brYJDEr
Patreon link: https://www.patreon.com/TheFuturistTom
Please follow our instagram at: https://www.instagram.com/the_futuris
For business inquires, please contact [email protected]

Jul 9, 2020

The Troubled Saga of Masa Son’s $100 Billion Fund

Posted by in categories: biotech/medical, business

SoftBank CEO Masayoshi Son’s Vision Fund has been impossible to ignore since its inception, pumping billions upon billions of dollars into tech companies like WeWork and Uber. Now, a string of high-profile losses and the coronavirus pandemic have put the fund deeply in the red. Bloomberg journalists Pavel Alpeyev, Sarah McBride and Tim Culpan break down the controversial investment strategies that have led to this critical moment for Son’s unprecedented fund.

Video by vicky feng and alan jeffries

Continue reading “The Troubled Saga of Masa Son’s $100 Billion Fund” »